{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:32:33Z","timestamp":1754152353989,"version":"3.41.2"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,18]]},"abstract":"<jats:p>This study analyzes the risk factors of unfavorable treatment outcomes in rifampicin-sensitive pulmonary tuberculosis (PTB) patients. Clinical data of 694 patients with rifampicin-sensitive PTB admitted to Quzhou Hospital Affiliated to Wenzhou Medical University from January 2020 to December 2021 were retrospectively analyzed. Univariate and multivariate logistic regression were used to analyze the related risk factors, and the predictive value was assessed using the receiver operating characteristic curve. Among 66 patients with unfavorable treatment outcomes, 42 died from non-tuberculosis causes, 16 died from tuberculosis, and 8 had failed treatment. Multivariate Logistic regression analysis showed that retreatment of PTB (odds ratio [<jats:italic toggle=\"yes\">OR<\/jats:italic>]\u2005=\u20052.750, 95% confidence interval [<jats:italic toggle=\"yes\">CI<\/jats:italic>] 1.253\u20136.033), chronic obstructive pulmonary disease (<jats:italic toggle=\"yes\">OR<\/jats:italic>\u2005=\u20053.229, 95% <jats:italic toggle=\"yes\">CI<\/jats:italic> 1.678\u20136.212), respiratory failure (<jats:italic toggle=\"yes\">OR<\/jats:italic>\u2005=\u20057.388, 95% <jats:italic toggle=\"yes\">CI<\/jats:italic> 2.420\u201322.560), elevated C-reactive protein (CRP) (<jats:italic toggle=\"yes\">OR<\/jats:italic>\u2005=\u20051.006, 95% <jats:italic toggle=\"yes\">CI<\/jats:italic> 1.000\u20131.011), hypoproteinemia (<jats:italic toggle=\"yes\">OR<\/jats:italic>\u2005=\u20050.902, 95% <jats:italic toggle=\"yes\">CI<\/jats:italic> 0.839\u20130.969), and low body mass index (BMI) (<jats:italic toggle=\"yes\">OR<\/jats:italic>\u2005=\u20050.976, 95% <jats:italic toggle=\"yes\">CI<\/jats:italic> 0.959\u20130.992) were independent risk factors for unfavorable treatment outcomes in rifampicin-sensitive PTB patients (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05); retreated of PTB (<jats:italic toggle=\"yes\">OR<\/jats:italic>\u2005=\u20055.347, 95% <jats:italic toggle=\"yes\">CI<\/jats:italic> 1.355\u201321.099), respiratory failure (<jats:italic toggle=\"yes\">OR<\/jats:italic>\u2005=\u200517.046, 95% <jats:italic toggle=\"yes\">CI<\/jats:italic> 3.080\u201394.354), hypoalbuminemia (<jats:italic toggle=\"yes\">OR<\/jats:italic>\u2005=\u20050.795, 95% <jats:italic toggle=\"yes\">CI<\/jats:italic> 0.702\u20130.902), and low BMI (<jats:italic toggle=\"yes\">OR<\/jats:italic>\u2005=\u20050.748, 95% <jats:italic toggle=\"yes\">CI<\/jats:italic> 0.584\u20130.959) were independent risk factors for poor prognosis in rifampicin-sensitive PTB patients (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). The area under the curve of CRP, serum albumin, and BMI combined to predict unfavorable treatment outcomes in PTB patients was 0.798 (95% <jats:italic toggle=\"yes\">CI<\/jats:italic> 0.749\u20130.847), with a sensitivity of 92.4% and specificity of 51.4%. The area under the curve of serum albumin and BMI combined to predict the prognosis of PTB patients was 0.923 (95% <jats:italic toggle=\"yes\">CI<\/jats:italic> 0.862\u20130.984), with a sensitivity of 93.8% and a specificity of 89.3%. The low BMI, hypoproteinemia, elevated CRP level, comorbidities, and retreatment are risk factors for unfavorable treatment outcomes and poor prognosis in patients with rifampicin-sensitive PTB. Serum albumin and BMI were good indicators for evaluating unfavorable treatment responses in rifampicin-sensitive PTB patients, and their combination could improve the accuracy of prognostic assessment.<\/jats:p>","DOI":"10.1097\/md.0000000000043262","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T04:02:04Z","timestamp":1753156924000},"page":"e43262","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of risk factors of unfavorable treatment outcomes in patients with rifampicin-sensitive pulmonary tuberculosis"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4356-6351","authenticated-orcid":false,"given":"Luyi","family":"Lv","sequence":"first","affiliation":[{"name":"The 2nd Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Ye","sequence":"additional","affiliation":[{"name":"The 2nd Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Lan","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Quzhou Affiliated Hospital of Wenzhou Medical University (Quzhou People\u2019s Hospital), Quzhou, Zhejiang Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Quzhou Affiliated Hospital of Wenzhou Medical University (Quzhou People\u2019s Hospital), Quzhou, Zhejiang Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyu","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Quzhou Affiliated Hospital of Wenzhou Medical University (Quzhou People\u2019s Hospital), Quzhou, Zhejiang Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shugen","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Quzhou Affiliated Hospital of Wenzhou Medical University (Quzhou People\u2019s Hospital), Quzhou, Zhejiang Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weili","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Quzhou Affiliated Hospital of Wenzhou Medical University (Quzhou People\u2019s Hospital), Quzhou, Zhejiang Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxian","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Quzhou Affiliated Hospital of Wenzhou Medical University (Quzhou People\u2019s Hospital), Quzhou, Zhejiang Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9062-3524","authenticated-orcid":false,"given":"Tao","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Quzhou Affiliated Hospital of Wenzhou Medical University (Quzhou People\u2019s Hospital), Quzhou, Zhejiang Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250722","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(19)30308-3","article-title":"Tuberculosis.","volume":"393","author":"Furin","year":"2019","journal-title":"Lancet"},{"key":"R3-20250722","first-page":"709","article-title":"Guidelines for the Diagnosis and Treatment of Tuberculosis at Primary Care Level (2018) [in Chinese].","volume":"18","year":"2019","journal-title":"Chin J Gen Practition"},{"key":"R4-20250722","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jinf.2023.06.014","article-title":"Global treatment outcomes of extensively drug-resistant tuberculosis in adults: a systematic review and meta-analysis.","volume":"87","author":"Pedersen","year":"2023","journal-title":"J Infect"},{"key":"R5-20250722","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.cmi.2023.12.001","article-title":"Treatment outcomes and risk factors for an unsuccessful outcome among patients with highly drug-resistant tuberculosis in Ukraine.","volume":"30","author":"Pedersen","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"R7-20250722","doi-asserted-by":"crossref","first-page":"e0000161","DOI":"10.1371\/journal.pgph.0000161","article-title":"Poor adult tuberculosis treatment outcome and associated factors in Gibe Woreda, Southern Ethiopia: an institution-based cross-sectional study.","volume":"2","author":"Mengesha","year":"2022","journal-title":"PLOS Glob Public Health"},{"key":"R8-20250722","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijtb.2020.09.022","article-title":"Risk factors for death during treatment in pulmonary tuberculosis patients in South India: a cohort study.","volume":"68","author":"Ramakrishnan","year":"2021","journal-title":"Indian J Tuberc"},{"key":"R9-20250722","first-page":"450","article-title":"Risk factors of treatment failure in smear-positive pulmonary tuberculosis patients [in Chinese].","volume":"38","author":"Wang","year":"2016","journal-title":"Chin J Antituberc"},{"key":"R10-20250722","doi-asserted-by":"crossref","first-page":"7706","DOI":"10.1038\/s41598-021-86994-6","article-title":"Spatial distribution and risk factors of adverse treatment outcomes of tuberculosis in Guizhou, China, 2013-2018.","volume":"11","author":"Zhou","year":"2021","journal-title":"Sci Rep"},{"key":"R11-20250722","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/eurpub\/ckx136","article-title":"Unsuccessful treatment in pulmonary tuberculosis: factors and a consequent predictive model.","volume":"28","author":"Costa-Veiga","year":"2018","journal-title":"Eur J Public Health"},{"key":"R12-20250722","doi-asserted-by":"crossref","first-page":"20434","DOI":"10.2807\/ese.18.12.20434-en","article-title":"Treatment outcome monitoring of pulmonary tuberculosis cases notified in France in 2009.","volume":"18","author":"Antoine","year":"2013","journal-title":"Euro Surveill"},{"key":"R13-20250722","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/MCP.0000000000000938","article-title":"Interrelationships between tuberculosis and chronic obstructive pulmonary disease.","volume":"29","author":"Zavala","year":"2023","journal-title":"Curr Opin Pulm Med"},{"key":"R14-20250722","doi-asserted-by":"crossref","first-page":"e62385","DOI":"10.1371\/journal.pone.0062385","article-title":"Increased cytokines response in patients with tuberculosis complicated with chronic obstructive pulmonary disease.","volume":"8","author":"Tang","year":"2013","journal-title":"PLoS One"},{"key":"R15-20250722","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1183\/09031936.00070907","article-title":"Pulmonary tuberculosis with acute respiratory failure.","volume":"32","author":"Kim","year":"2008","journal-title":"Eur Respir J"},{"key":"R16-20250722","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.micinf.2016.10.001","article-title":"The bacillary and macrophage response to hypoxia in tuberculosis and the consequences for T cell antigen recognition.","volume":"19","author":"Prosser","year":"2017","journal-title":"Microbes Infect"},{"key":"R17-20250722","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0163-4453(90)90669-Y","article-title":"Predicting deterioration of treated tuberculosis by corticosteroid reserve and C-reactive protein.","volume":"21","author":"Scott","year":"1990","journal-title":"J Infect"},{"key":"R18-20250722","doi-asserted-by":"crossref","first-page":"1005692","DOI":"10.3389\/fimmu.2022.1005692","article-title":"Reduction of blood C-reactive protein concentration complements the resolution of sputum bacillary load in patients on anti-tuberculosis therapy.","volume":"13","author":"Azam","year":"2022","journal-title":"Front Immunol"},{"key":"R19-20250722","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1093\/jn\/130.12.2953","article-title":"Poor micronutrient status of active pulmonary tuberculosis patients in Indonesia.","volume":"130","author":"Karyadi","year":"2000","journal-title":"J Nutr"},{"key":"R20-20250722","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jiac.2019.07.008","article-title":"The impact of performance status on tuberculosis-related death among elderly patients with lung tuberculosis: a competing risk regression analysis.","volume":"26","author":"Honjo","year":"2020","journal-title":"J Infect Chemother"},{"key":"R21-20250722","first-page":"681","article-title":"Use of serum albumin level as a predictive marker of clinical outcomes for active tuberculosis.","volume":"50","author":"Liu","year":"2020","journal-title":"Ann Clin Lab Sci"},{"key":"R22-20250722","doi-asserted-by":"crossref","first-page":"e392","DOI":"10.1093\/cid\/ciaa054","article-title":"Impact of diabetes and low body mass index on tuberculosis treatment outcomes.","volume":"71","author":"Kornfeld","year":"2020","journal-title":"Clin Infect Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T04:02:07Z","timestamp":1753156927000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":20,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043262","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2025,7,18]]}}}